Published in J Am Acad Dermatol on September 01, 1995
A centimeter there, a centimeter there: does it matter? J Am Acad Dermatol (1996) 0.75
A centimeter here, a centimeter there. J Am Acad Dermatol (1996) 0.75
Surgical margins for malignant melanoma: another point of view. J Am Acad Dermatol (1996) 0.75
High-dose interferon alfa-2b significantly prolongs relapse-free and overall survival compared with the GM2-KLH/QS-21 vaccine in patients with resected stage IIB-III melanoma: results of intergroup trial E1694/S9512/C509801. J Clin Oncol (2001) 4.84
High- and low-dose interferon alfa-2b in high-risk melanoma: first analysis of intergroup trial E1690/S9111/C9190. J Clin Oncol (2000) 4.60
Predictions and measurements of scattering and absorption over broad wavelength ranges in tissue phantoms. Appl Opt (1997) 3.40
Mechanisms of light scattering from biological cells relevant to noninvasive optical-tissue diagnostics. Appl Opt (1998) 3.33
Recovery of phospho-ERK activity allows melanoma cells to escape from BRAF inhibitor therapy. Br J Cancer (2010) 2.83
Medical issues and emergencies in the dermatology office. J Am Acad Dermatol (1997) 2.11
Trichoblastic fibroma. A series of 10 cases with report of a new plaque variant. Arch Dermatol (1995) 2.08
Use of chest radiography in the initial evaluation of patients with localized melanoma. Arch Dermatol (1998) 2.01
Light scattering from cells: the contribution of the nucleus and the effects of proliferative status. J Biomed Opt (2000) 1.79
Polarized angular dependent spectroscopy of epithelial cells and epithelial cell nuclei to determine the size scale of scattering structures. J Biomed Opt (2002) 1.78
Liposarcoma of the spermatic cord: report of 6 cases and review of the literature. J Urol (1995) 1.76
Sebaceous carcinoma. J Am Acad Dermatol (1995) 1.75
Treatment of metastatic cancer with tetrathiomolybdate, an anticopper, antiangiogenic agent: Phase I study. Clin Cancer Res (2000) 1.74
The association of nocturia with incident falls in an elderly community-dwelling cohort. Int J Clin Pract (2010) 1.69
Randomized trial of adjuvant human interferon gamma versus observation in high-risk cutaneous melanoma: a Southwest Oncology Group study. J Natl Cancer Inst (1995) 1.67
Basaloid follicular hamartoma: a histologic diagnosis with diverse clinical presentations. Arch Dermatol (1993) 1.52
Do primary small intestinal melanomas exist? Report of a case. J Am Acad Dermatol (1999) 1.46
Screening for amblyogenic factors using a volunteer lay network and the MTI photoscreener. Initial results from 15,000 preschool children in a statewide effort. Ophthalmology (2000) 1.44
Managing patients. Fam Med (1995) 1.40
A surgical wound infection due to Mycobacterium chelonae successfully treated with clarithromycin. Dermatol Surg (1997) 1.39
Burnout syndrome. Br Dent J (2006) 1.38
Bisphenol alert. Br Dent J (2008) 1.38
Clinical improvement following dermabrasion of photoaged skin correlates with synthesis of collagen I. Arch Dermatol (1994) 1.36
Mohs micrographic surgery for the treatment of dermatofibrosarcoma protuberans. Results of a multiinstitutional series with an analysis of the extent of microscopic spread. J Am Acad Dermatol (1997) 1.36
Role of the plasminogen activator and matrix metalloproteinase systems in epidermal growth factor- and scatter factor-stimulated invasion of carcinoma cells. Cancer Res (1998) 1.30
Evidence of intrinsic differences in the light scattering properties of tumorigenic and nontumorigenic cells. Cancer (1998) 1.28
Merkel cell carcinoma. J Am Acad Dermatol (1993) 1.26
Cytomegalovirus infection increases development of atherosclerosis in Apolipoprotein-E knockout mice. Atherosclerosis (2001) 1.25
Editing data: what difference do consistency checks make? Am J Epidemiol (2000) 1.21
Solitary melanoma confined to the dermal and/or subcutaneous tissue: evidence for revisiting the staging classification. Arch Dermatol (2000) 1.19
Age-related differences in breast cancer treatment. Ann Surg Oncol (1994) 1.18
Adoptive immunotherapy with vaccine-primed lymph node cells secondarily activated with anti-CD3 and interleukin-2. J Clin Oncol (1997) 1.17
AIDS exacerbates psoriasis. N Engl J Med (1985) 1.15
Characterizing Mammalian cells and cell phantoms by polarized backscattering fiber-optic measurements. Appl Opt (2001) 1.15
Measuring absorption coefficients in small volumes of highly scattering media: source-detector separations for which path lengths do not depend on scattering properties. Appl Opt (1997) 1.14
The pro-longevity gene FoxO3 is a direct target of the p53 tumor suppressor. Oncogene (2011) 1.13
Rac1 is required for cell proliferation and G2/M progression. Biochem J (1997) 1.11
Clinical correlations with chemosensitivities measured in a rapid thymidine incorporation assay. Cancer Res (1984) 1.09
The multidisciplinary melanoma clinic: a cost outcomes analysis of specialty care. J Am Acad Dermatol (1998) 1.08
Collagenolytic and gelatinolytic matrix metalloproteinases and their inhibitors in basal cell carcinoma of skin: comparison with normal skin. Br J Cancer (2000) 1.07
Pertussis toxin-sensitive G proteins as mediators of the signal transduction pathways activated by cytomegalovirus infection of smooth muscle cells. J Clin Invest (1997) 1.06
Non-invasive measurement of chemotherapy drug concentrations in tissue: preliminary demonstrations of in vivo measurements. Phys Med Biol (1999) 1.06
Aging is associated with increased HbA1c levels, independently of glucose levels and insulin resistance, and also with decreased HbA1c diagnostic specificity. Diabet Med (2014) 1.05
Guidelines of care for primary cutaneous melanoma. J Am Acad Dermatol (2001) 1.05
Effects of human cytomegalovirus immediate-early proteins on p53-mediated apoptosis in coronary artery smooth muscle cells. Circulation (1999) 1.04
Chemosensitivity testing of human solid tumors. A review of 1582 assays with 258 clinical correlations. Cancer (1984) 1.04
Carbonic anhydrase II deficiency syndrome in a Belgian family is caused by a point mutation at an invariant histidine residue (107 His----Tyr): complete structure of the normal human CA II gene. Am J Hum Genet (1991) 1.03
Clinical observations on adoptive immunotherapy with vaccine-primed T-lymphocytes secondarily sensitized to tumor in vitro. Cancer Res (1993) 1.02
Regulation of amylase gene expression in diabetic mice is mediated by a cis-acting upstream element close to the pancreas-specific enhancer. Genes Dev (1990) 1.02
CT of recurrent retroperitoneal sarcomas. AJR Am J Roentgenol (2000) 1.01
Type 1 versus type 2 cytokine release by Vbeta T cell subpopulations determines in vivo antitumor reactivity: IL-10 mediates a suppressive role. J Immunol (1997) 1.01
Traumatic asphyxia. J Am Acad Dermatol (1990) 1.01
Complete spontaneous regression of pulmonary metastatic melanoma. Dermatol Surg (1998) 0.99
Papulonodular dermal mucinosis in lupus erythematosus. J Am Acad Dermatol (1992) 0.99
Malignant melanoma of the foot and ankle. J Bone Joint Surg Am (1995) 0.97
Acquired immunodeficiency syndrome-associated psoriasis and Reiter's syndrome. Arch Dermatol (1987) 0.97
Gender and other survival predictors in patients with metastatic melanoma on Southwest Oncology Group trials. Cancer (2001) 0.97
Development of a miniaturized, improved nucleic acid precursor incorporation assay for chemosensitivity testing of human solid tumors. Cancer Res (1985) 0.96
Treatment of keratoacanthomas with intralesional methotrexate. J Am Acad Dermatol (1991) 0.96
Mucinous carcinoma of the skin. J Am Acad Dermatol (1997) 0.95
Animal-type melanoma: a clinical and histopathological study of 22 cases from a single institution. Br J Dermatol (2009) 0.95
Galectin-3 modulates ureteric bud branching in organ culture of the developing mouse kidney. J Am Soc Nephrol (2001) 0.94
Immunotherapy of advanced malignancy by direct gene transfer of an interleukin-2 DNA/DMRIE/DOPE lipid complex: phase I/II experience. J Clin Oncol (1999) 0.94
Elastic scattering spectroscopy as a diagnostic tool for differentiating pathologies in the gastrointestinal tract: preliminary testing. J Biomed Opt (1996) 0.93
Evidence for leptin expression in fishes. J Exp Zool (2000) 0.92
Superoxide-mediated actin response in post-hypoxic endothelial cells. J Biol Chem (1996) 0.92
Pharmacokinetic/pharmacodynamic analysis of adjuvant pegylated interferon α-2b in patients with resected high-risk melanoma. Cancer Chemother Pharmacol (2010) 0.91
De novo design of peptides targeted to the EF hands of calmodulin. J Biol Chem (2000) 0.91
Self-rated sleep characteristics and bother from nocturia. Int J Clin Pract (2012) 0.90
Autophosphorylation induces autoactivation and a decrease in the Src homology 2 domain accessibility of the Lyn protein kinase. J Biol Chem (1995) 0.90
Binding of a pancreatic nuclear protein is correlated with amylase enhancer activity. Nucleic Acids Res (1989) 0.90
The forehead flap for nasal reconstruction. Arch Dermatol (2000) 0.90
Analysis of the clinical utility of a predictive chemosensitivity assay. Stat Med (1986) 0.89
Efficient transgenic plant regeneration throughAgrobacterium-mediated transformation of Chickpea (Cicer arietinum L.). Plant Cell Rep (1996) 0.89
Production and characterization of monoclonal antibodies against a highly immunogenic fraction of Entamoeba histolytica (NIH:200) and their application in the detection of current amoebic infection. J Eukaryot Microbiol (1994) 0.89
Computed tomography in staging of patients with melanoma metastatic to the regional nodes. Ann Surg Oncol (1997) 0.88
Phase I clinical trial of the Src inhibitor dasatinib with dacarbazine in metastatic melanoma. Br J Cancer (2011) 0.88
The role of dermabrasion and chemical peels in the treatment of patients with xeroderma pigmentosum. J Am Acad Dermatol (1995) 0.88
Expression of 12-lipoxygenase as a biomarker for melanoma carcinogenesis. Melanoma Res (2002) 0.88
A modified p53 overcomes mdm2-mediated oncogenic transformation: a potential cancer therapeutic agent. Cancer Res (2000) 0.88
Metastatic melanoma from intraocular primary tumors: the Southwest Oncology Group experience in phase II advanced melanoma clinical trials. Am J Clin Oncol (1998) 0.87
The subcutaneous pedicle flap in melolabial reconstruction. Arch Otolaryngol Head Neck Surg (1998) 0.87
Phase II trial of recombinant human interleukin-4 in patients with disseminated malignant melanoma: a Southwest Oncology Group study. J Immunother (1998) 0.87
Phase II study of carmustine, dacarbazine, cisplatin, and tamoxifen in advanced melanoma: a Southwest Oncology Group study. J Clin Oncol (1998) 0.86
The utility of fine needle aspiration in the diagnosis of melanoma metastatic to lymph nodes. J Am Acad Dermatol (1997) 0.86
Microcystic adnexal carcinoma. J Am Acad Dermatol (1993) 0.85
Phase II trial of biochemotherapy with interferon alpha, dacarbazine, cisplatin and tamoxifen in metastatic melanoma: a Southwest Oncology Group trial. J Cancer Res Clin Oncol (1999) 0.85
Perineural spread of basal cell carcinomas treated with Mohs micrographic surgery. Cancer (2000) 0.85
Increased expression of matrix metalloproteinase-3 (stromelysin-1) in cultured fibroblasts and basal cell carcinomas of nevoid basal cell carcinoma syndrome. Mol Carcinog (1994) 0.85
Lafora disease: diagnosis by skin biopsy. J Am Acad Dermatol (1999) 0.84
Evaluation of a perinatal grief support team. Am J Obstet Gynecol (1987) 0.84
Adenocarcinoma in a choledochal cyst during pregnancy: a case report and guidelines for management. Surgery (1988) 0.84
Basic suture materials and suturing techniques. Semin Dermatol (1994) 0.83
Economic implications of hepatic arterial infusion chemotherapy in treatment of nonresectable colorectal liver metastases. Meta-Analysis Group in Cancer. J Natl Cancer Inst (1997) 0.83
Age-based refinement of referral criteria for photoscreening. Ophthalmology (2001) 0.83